Navigation Links
PharmaSmart International, Inc and AstraZeneca Canada Enter Into Strategic Partnership to Elevate Pharmacy Based Hypertension Management
Date:12/30/2009

PharmaSmart International, Inc., an award winning Inc. 5000 company and "Top 100" Rochester, NY Growth Company, is partnering with AstraZeneca Canada to deliver innovative tools and programs to pharmacists, physicians and patients for the improved management of hypertension. The partnership program positions community pharmacy at the front lines of disease state management, and will involve a select group of Canadian retail pharmacy participants.

Rochester, NY (PRWEB) December 30, 2009 -- PharmaSmart International, Inc., an award winning Inc. 5000 company and "Top 100" Rochester, NY Growth Company, is partnering with AstraZeneca Canada to deliver innovative tools and programs to pharmacists, physicians and patients for the improved management of hypertension. The partnership program positions community pharmacy at the front lines of disease state management, and will involve a select group of Canadian retail pharmacy participants. More details and timelines will be released at a later date.

“The AstraZeneca Canada partnership further strengthens our commitment to the retail pharmacy and the patient community, and aligns well with our mission and core competency,” states Ashton S. Maaraba, PharmaSmart’s Senior Vice President/GM, Global Sales & Operations. “Hypertension is the #1 contributor to premature death in North America. By combining our technology and programs with the strength and expertise of companies like AstraZeneca Canada, we can better combat this deadly disease. This program launch is the result of hard work by both the PharmaSmart and AstraZeneca Canada teams, as well as the vision and commitment of the select retail partners. Our shared vision and commitment made the partnership a reality.”

Josh Sarkis, PharmaSmart’s, Senior Vice President/GM, Strategic Business Development, stated, “It is now widely acknowledged that chronic diseases such as hypertension are best managed with the help of community based health professionals. By providing pharmacists with innovative technology, patient tools and educational support, we believe that we can help today’s pharmacy achieve its full potential in terms of managing the hypertensive patient. We are extremely pleased to be partnering with AstraZeneca Canada and our retail partners in a program that will accelerate this important evolution in pharmacy based healthcare.”

PharmaSmart, headquartered in Rochester, NY, USA, is a world leader in blood pressure screening technology, providing innovative solutions to meet the needs of medical providers, employers, pharmacists, and patients to test, track, and manage blood pressure. PharmaSmart equipment currently performs over 65 million blood pressure tests per year. PharmaSmart’s unique services, technology, and data integration capabilities are utilized by chain pharmacies, corporate worksites, fitness facilities, and medical clinics as a core disease state management solution.

For more information visit the company's website at www.pharma-smart.com or contact Corporate Communications Mary Ann Rutkowski at (800) 781-0323.

###

Read the full story at http://www.prweb.com/releases/PharmaSmart/AstraZeneca_Canada/prweb3392894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services
2. PharmaSmart International Announces Integration with Microsoft HealthVault
3. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
4. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
5. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
6. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
7. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
8. Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
9. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
10. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
11. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PharmaSmart International, Inc and AstraZeneca Canada Enter Into Strategic Partnership to Elevate Pharmacy Based Hypertension Management
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology: